Transplantation-Associated Microangiopathy (TAM) in Recipients of HLA-Haploidentical Hematopoietic Stem Cell Transplants Using Ptcy, CNI and MMF for GvHD Prophylaxis

MLA

Wolfgang Hiddemann, et al. “Transplantation-Associated Microangiopathy (TAM) in Recipients of HLA-Haploidentical Hematopoietic Stem Cell Transplants Using Ptcy, CNI and MMF for GvHD Prophylaxis.” Blood, vol. 134, Nov. 2019, p. 1982. EBSCOhost, https://doi.org/10.1182/blood-2019-130685.

APA

Wolfgang Hiddemann, Veit Bücklein, Johanna Tischer, Alessia Fraccaroli, Sarah Haebe, Ulf Schoenermarck, Michael von Bergwelt, Dusan Prevalsek, & Heidrun Drolle. (2019). Transplantation-Associated Microangiopathy (TAM) in Recipients of HLA-Haploidentical Hematopoietic Stem Cell Transplants Using Ptcy, CNI and MMF for GvHD Prophylaxis. Blood, 134, 1982. https://doi.org/10.1182/blood-2019-130685

Chicago

Wolfgang Hiddemann, Veit Bücklein, Johanna Tischer, Alessia Fraccaroli, Sarah Haebe, Ulf Schoenermarck, Michael von Bergwelt, Dusan Prevalsek, and Heidrun Drolle. 2019. “Transplantation-Associated Microangiopathy (TAM) in Recipients of HLA-Haploidentical Hematopoietic Stem Cell Transplants Using Ptcy, CNI and MMF for GvHD Prophylaxis.” Blood 134 (November): 1982. doi:10.1182/blood-2019-130685.